RTTNews | Nov 30, 2021 10:16AM EST

10:15 Tuesday, November 30, 2021 (RTTNews.com) - Shares of German biotechnology company BioNTech SE (BNTX) are moving down 6 percent on Tuesday's trading even while there is renewed focus on vaccine makers with the discovery of the omicron variant of the coronavirus.

In another development, Moderna's CEO expressed apprehensions about the effectiveness of vaccines against the newly identified variant.

According to reports, Covid-19 vaccine manufacturers like BioNTech, Pfizer are already looking to modify their existing vaccine shots to include protection from the omicron variant.

Currently at $338.88, the stock has traded between $80.55 and $464.00 during the past 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3245759/biontech-shares-slip-6-amid-omicron-variant-concerns.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved